Advertisement
Research Article| Volume 42, ISSUE 12, P1839-1847, August 2006

Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands

  • R. Hoopman
    Affiliations
    Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

    Institute for Research in Extramural Medicine, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
    Search for articles by this author
  • M.J. Muller
    Affiliations
    Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Search for articles by this author
  • C.B. Terwee
    Affiliations
    Institute for Research in Extramural Medicine, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
    Search for articles by this author
  • N.K. Aaronson
    Correspondence
    Corresponding author: Tel.: +31 20 512 2481; fax: +31 20 512 2322.
    Affiliations
    Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Search for articles by this author

      Abstract

      The purpose of this study was to validate the core EORTC quality of life questionnaire, the QLQ-C30 (version 3.0), for use among Turkish and Moroccan cancer patients in the Netherlands. The questionnaire was translated into two oral Moroccan languages , and the existing Turkish version was culturally adapted for use in the Netherlands. Ninety Turkish and 79 Moroccan patients completed the questionnaire. Administration of the questionnaire proved feasible, with low levels of missing questionnaires (4%) and missing items (on average, 1.5–2.4%). With one minor exception, the evidence of convergent validity was strong for all multi-item scales. Internal consistency reliability was above 0.70 for all scales except the cognitive functioning scale in the Turkish sample. The questionnaire was able to distinguish clearly between subgroups formed on the basis of performance status and comorbidity, and was moderately responsive to change over time in performance status. These data support the use of the QLQ-C30 among Turkish and Moroccan cancer patients residing in the Netherlands. Additional studies are needed to confirm the psychometrics of the questionnaire when used among these ethnic minority groups residing in other Western European countries.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Salt J. European international migration: evaluations of the current situation. Strasbourg, Council of Europe; 2002.

        • Aaronson N.K.
        • Bullinger M.
        • Ahmedzai S.
        A modular approach to quality-of-life assessment in cancer clinical trials.
        Recent Results Cancer Res. 1988; 111: 231-249
        • Aaronson N.K.
        • Ahmedzai S.
        • Bergman B.
        • Bullinger M.
        • Cull A.
        • Duez N.J.
        • et al.
        The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
        J Natl Cancer Inst. 1993; 85: 365-376
        • Guzelant A.
        • Goksel T.
        • Ozkok S.
        • Tasbakan S.
        • Aysan T.
        • Bottomley A.
        The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
        Eur J Cancer Care (Engl). 2004; 13: 135-144
      2. Cull A, Sprangers MA, Bjordal K, Aaronson NK. on behalf of the EORTC Quality of Life Study Group. EORTC Quality of life study group translation procedure. Brussels, EORTC Quality of Life Study Group; 1988.

      3. De Ruiter JJ. Talen in Nederland. Groningen, the Netherlands, Wolters-Noordhoff bv.; 1991.

        • Karnofsky D.A.
        • Burchenal J.H.
        The clinical evaluation of chemotherapeutic agents in cancer.
        in: MacLeod C.M. Evaluation of chemotherapeutic agents. Colombia University, New York1949: 199-205
        • Schaafsma J.
        • Osoba D.
        The Karnofsky performance status scale re-examined: a cross-validation with the EORTC-C30.
        Qual Life Res. 1994; 3: 413-424
        • Schag C.C.
        • Heinrich R.L.
        • Ganz P.A.
        Karnofsky performance status revisited: reliability, validity, and guidelines.
        J Clin Oncol. 1984; 2: 187-193
        • Ware J.E.
        • Harris W.J.
        • Gandek B.
        • Rogers B.W.
        • Reese P.R.
        MAP-R for windows: multitrait multi-item analysis program – revised user’s guide.
        Health Assessment Lab, Boston, MA1997
        • Cronbach L.J.
        Coefficient alpha and the internal structure of tests.
        Psychometrika. 1951; 16: 297-334
        • Arraras J.I.
        • Arias F.
        • Tejedor M.
        • Pruja E.
        • Marcos M.
        • Martinez E.
        • et al.
        The EORTC QLQ-C30 (version 3.0) quality of life questionnaire: validation study for Spain with head and neck cancer patients.
        Psychooncology. 2002; 11: 249-256
        • Elliott B.A.
        • Renier C.M.
        • Haller I.V.
        • Elliott T.E.
        Health-related quality of life (HRQoL) in patients with cancer and other concurrent illnesses.
        Qual Life Res. 2004; 13: 457-462
        • Osoba D.
        • Zee B.
        • Pater J.
        • Warr D.
        • Kaizer L.
        • Latreille J.
        Psychometric properties and responsiveness of the EORTC quality of life questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.
        Qual Life Res. 1994; 3: 353-364
        • Knipscheer J.W.
        • Kleber R.J.
        A need for ethnic similarity in the therapist-patient interaction? Mediterranean migrants in Dutch mental-health care.
        J Clin Psychol. 2004; 60: 543-554
        • Van der Wurff F.B.
        • Beekman A.T.
        • Dijkshoorn H.
        • Spijker J.A.
        • Smits C.H.
        • Stek M.L.
        • et al.
        Prevalence and risk-factors for depression in elderly Turkish and Moroccan migrants in the Netherlands.
        J Affect Disord. 2004; 83: 33-41
        • Wiking E.
        • Johansson S.E.
        • Sundquist J.
        Ethnicity, acculturation, and self reported health. A population based study among immigrants from Poland, Turkey, and Iran in Sweden.
        J Epidemiol Community Health. 2004; 58: 574-582
        • Ertan T.
        • Richards M.
        • Eker E.
        Problems in cross-cultural psychogeriatric research: contacting older Turkish immigrants in the UK.
        Int J Geriatr Psychiatry. 1999; 14: 892-893
      4. Visser L, Uitewaal, PJM, Bruijnzeels, MA. Recruitment and follow up of ethnic minority patients in clinical studies. Ethnic Health 2004; 9(1):30. Migrant Health in Europe. In: Proceedings of the international conference on differences in health and health care provision, 23–25 June 2004 Rotterdam, the Netherlands.

        • Montazeri A.
        • Harirchi I.
        • Vahdani M.
        • Khaleghi F.
        • Jarvandi S.
        • Ebrahimi M.
        • et al.
        The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version.
        Support Care Cancer. 1999; 7: 400-406
        • Zhao H.
        • Kanda K.
        Translation and validation of the standard Chinese version of the EORTC QLQ-C30.
        Qual Life Res. 2000; 9: 129-137
        • Di Maio M.
        • Perrone F.
        Quality of life in elderly patients with cancer.
        Health Qual Life Outcomes. 2003; 1: 44
        • Rosal M.C.
        • Carbone E.T.
        • Goins K.V.
        Use of cognitive interviewing to adapt measurement instruments for low-literate Hispanics.
        Diabetes Educ. 2003; 29: 1006-1017
        • Aaronson N.K.
        Cross-cultural use of health-related quality of life assessments in clinical oncology.
        in: Lipscomb J. Gotay C.C. Snyder C.F. Outcomes assessment in cancer. Cambridge University Press, Cambridge2005: 406-424
        • Kaasa S.
        • Bjordal K.
        • Aaronson N.
        • Moum T.
        • Wist E.
        • Hagen S.
        • et al.
        The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy.
        Eur J Cancer. 1995; 31A: 2260-2263
        • Kyriaki M.
        • Eleni T.
        • Efi P.
        • Ourania K.
        • Vassilios S.
        • Lambros V.
        The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample.
        Int J Cancer. 2001; 94: 135-139
        • Montazeri A.
        • Harirchi I.
        • Vahdani M.
        • Khaleghi F.
        • Jarvandi S.
        • Ebrahimi M.
        • et al.
        The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version.
        Qual Life Res. 2000; 9: 177-184